​

Hims & Hers Health (HIMS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HIMS Stock Forecast

Hims & Hers Health (HIMS) stock forecast, based on 19 Wall Street analysts, predicts a 12-month average price target of $29.92, with a high of $60.00 and a low of $12.50. This represents a 15.61% increase from the last price of $25.88.

$5 $16 $27 $38 $49 $60 High: $60 Avg: $29.92 Low: $12.5 Last Closed Price: $25.88

HIMS Stock Rating

Hims & Hers Health stock's rating consensus is Hold, based on 19 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (31.58%), 13 Hold (68.42%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 19 0 13 6 Strong Sell Sell Hold Buy Strong Buy

HIMS Price Target Upside V Benchmarks

TypeNameUpside
StockHims & Hers Health15.61%
SectorHealthcare Stocks 15.45%

Price Target Trends

1M3M12M
# Anlaysts71121
Avg Price Target$21.14$26.18$34.81
Last Closing Price$25.88$25.88$25.88
Upside/Downside-18.32%1.16%34.51%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2621101115
Feb, 2612101115
Jan, 261281214
Dec, 25-281213
Nov, 25-382114
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 09, 2026Ryan MacDonaldNeedham$30.00$22.3534.23%15.92%
Mar 09, 2026Oppenheimer$12.50$21.58-42.08%-51.70%
Feb 24, 2026Barclays$25.00$15.9157.13%-3.40%
Feb 24, 2026Craig HettenbachMorgan Stanley$21.00$14.3846.04%-18.86%
Feb 24, 2026Evercore ISI$24.00$14.1070.21%-7.26%
Feb 24, 2026Jailendra SinghTruist Financial$18.00$15.5116.05%-30.45%
Feb 24, 2026Leerink Partners$17.50$15.5112.83%-32.38%
Feb 10, 2026George HillDeutsche Bank$31.00$18.2569.86%19.78%
Feb 09, 2026Michael ChernyLeerink Partners$20.00$17.3515.27%-22.72%
Feb 02, 2026BTIG$60.00$27.09121.48%131.84%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 10, 2026Bank of America SecuritiesPositiveNeutralupgrade
Mar 09, 2026NeedhamHoldSellupgrade
Mar 09, 2026BTIGNeutralNeutralhold
Mar 09, 2026Bank of America SecuritiesPositivePositivehold
Feb 24, 2026Cowen & Co.HoldHoldhold
Feb 24, 2026KeyBancSector WeightSector Weighthold
Feb 24, 2026BTIGNeutraldowngrade
Feb 10, 2026Deutsche BankHoldHoldhold
Feb 09, 2026Leerink PartnersMarket PerformMarket Performhold
Jan 08, 2026Bank of America SecuritiesUnderperformUnderperformhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.58$-0.32$-0.11$0.58$0.57---
Avg Forecast$-0.36$-0.32$-0.13$0.54$0.52$0.72$0.84$0.56
High Forecast$-0.34$-0.28$-0.11$0.58$0.70$0.98$1.19$0.62
Low Forecast$-0.40$-0.35$-0.15$0.50$0.28$0.39$0.45$0.46
Surprise %61.11%--15.38%7.41%9.62%---

Revenue Forecast

$0 $700M $1B $2B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$271.88M$526.92M$872.00M$1.48B$2.35B---
Avg Forecast$264.20M$520.90M$871.89M$1.46B$2.04B$2.35B$2.74B$2.83B
High Forecast$282.12M$557.08M$872.88M$1.47B$2.21B$2.36B$2.78B$3.06B
Low Forecast$249.87M$469.87M$870.58M$1.45B$1.78B$2.34B$2.70B$2.46B
Surprise %2.90%1.15%0.01%1.12%14.84%---

Net Income Forecast

$-150M $-70M $10M $90M $170M $250M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-107.66M$-65.68M$-23.55M$126.04M$128.37M---
Avg Forecast$-108.55M$-67.50M$-23.55M$113.41M$120.85M$172.21M$238.96M$117.23M
High Forecast$-86.84M$-58.90M$-18.84M$121.66M$146.94M$204.73M$248.44M$129.47M
Low Forecast$-130.26M$-73.59M$-28.26M$105.16M$58.78M$81.25M$94.80M$97.17M
Surprise %-0.82%-2.69%-11.14%6.22%---

HIMS Forecast FAQ

Is Hims & Hers Health stock a buy?

Hims & Hers Health stock has a consensus rating of Hold, based on 19 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 13 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Hims & Hers Health is a neutral investment for most analysts.

What is Hims & Hers Health's price target?

Hims & Hers Health's price target, set by 19 Wall Street analysts, averages $29.92 over the next 12 months. The price target range spans from $12.5 at the low end to $60 at the high end, suggesting a potential 15.61% change from the previous closing price of $25.88.

How does Hims & Hers Health stock forecast compare to its benchmarks?

Hims & Hers Health's stock forecast shows a 15.61% upside, outperforming the average forecast for the healthcare stocks sector (15.45%).

What is the breakdown of analyst ratings for Hims & Hers Health over the past three months?

  • March 2026: 13.33% Strong Buy, 6.67% Buy, 66.67% Hold, 6.67% Sell, 6.67% Strong Sell.
  • February 2026: 6.67% Strong Buy, 13.33% Buy, 66.67% Hold, 6.67% Sell, 6.67% Strong Sell.
  • January 2026: 7.14% Strong Buy, 14.29% Buy, 57.14% Hold, 7.14% Sell, 14.29% Strong Sell.

What is Hims & Hers Health’s EPS forecast?

Hims & Hers Health's average annual EPS forecast for its fiscal year ending in December 2026 is $0.72, marking a 26.32% increase from the reported $0.57 in 2025. Estimates for the following years are $0.84 in 2027, and $0.56 in 2028.

What is Hims & Hers Health’s revenue forecast?

Hims & Hers Health's average annual revenue forecast for its fiscal year ending in December 2026 is $2.35B, reflecting a -0.00% decrease from the reported $2.35B in 2025. The forecast for 2027 is $2.74B, and $2.83B for 2028.

What is Hims & Hers Health’s net income forecast?

Hims & Hers Health's net income forecast for the fiscal year ending in December 2026 stands at $172.21M, representing an 34.15% increase from the reported $128.36M in 2025. Projections indicate $238.96M in 2027, and $117.23M in 2028.